| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Aptinyx Inc (NASDAQ: APTX)
APTX Technical Analysis
5
| As on 9th Jun 2023 APTX STOCK Price closed @ 0.07 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.32 & Strong Sell for SHORT-TERM with Stoploss of 2.99 we also expect STOCK to react on Following IMPORTANT LEVELS. |
APTXSTOCK Price
| Open | 0.07 | Change | Price | % |
| High | 0.07 | 1 Day | 0.00 | 0.00 |
| Low | 0.07 | 1 Week | 0.00 | 0.00 |
| Close | 0.07 | 1 Month | -0.05 | -41.67 |
| Volume | 400675 | 1 Year | -2.50 | -97.28 |
| 52 Week High 3.62 | 52 Week Low 0.06 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| APTX Daily Charts |
APTX Intraday Charts |
Whats New @ Bazaartrend |
APTX Free Analysis |
|
|
APTX Important Levels Intraday
| RESISTANCE | 0.07 |
| RESISTANCE | 0.07 |
| RESISTANCE | 0.07 |
| RESISTANCE | 0.07 |
| RESISTANCE | 0.07 |
| RESISTANCE | 0.07 |
| RESISTANCE | 0.07 |
| RESISTANCE | 0.07 |
APTX Forecast May 2024
| 4th UP Forecast | 2.29 |
| 3rd UP Forecast | 1.58 |
| 2nd UP Forecast | 1.14 |
| 1st UP Forecast | 0.7 |
| 1st DOWN Forecast | -0.56 |
| 2nd DOWN Forecast | -1 |
| 3rd DOWN Forecast | -1.44 |
| 4th DOWN Forecast | -2.15 |
APTX Weekly Forecast
| 4th UP Forecast | 0.88 |
| 3rd UP Forecast | 0.62 |
| 2nd UP Forecast | 0.46 |
| 1st UP Forecast | 0.30 |
| 1st DOWN Forecast | -0.16 |
| 2nd DOWN Forecast | -0.32 |
| 3rd DOWN Forecast | -0.48 |
| 4th DOWN Forecast | -0.74 |
APTX Forecast2024
| 4th UP Forecast | 7.22 |
| 3rd UP Forecast | 4.93 |
| 2nd UP Forecast | 3.51 |
| 1st UP Forecast | 2.09 |
| 1st DOWN Forecast | -1.95 |
| 2nd DOWN Forecast | -3.37 |
| 3rd DOWN Forecast | -4.79 |
| 4th DOWN Forecast | -7.08 |
Aptinyx Inc ( NASDAQ USA Symbol : APTX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
APTX Business Profile
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic peripheral neuropathy, as well as in Phase II clinical trial for treating fibromyalgia. It is also developing NYX-783, an N-methyl-D-aspartate receptors (NMDAr) modulator that is in Phase I clinical trial to treat post-traumatic stress disorder; and NYX-458, an NMDAr modulator, which is in Phase I clinical study for the treatment of Parkinson's disease cognitive impairment. The company has a research collaboration agreement with Allergan plc; and with Rosalind Franklin University of Medicine and Science. Aptinyx Inc. was incorporated in 2015 and is headquartered in Evanston, Illinois. Address: 909 Davis Street, Evanston, IL, United States, 60201
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service